Guangzhou R&F Properties Co Ltd (2777)
Hong Kong Stock Exchange · Hong Kong · prices in HKD · close of 27 Oct 2026
Key indicators
| Last close | HKD 0.191 |
|---|---|
| 52-week range | 0.110 – 0.690 |
| Return, 1 month / 3 months | +39.4% / −12.4% |
| Return, 1 year / 3 years | −68.7% / −82.6% |
| Trend | Below its 200-day average |
| RSI (14) | 50 |
| Volatility (1 year) | 73.0% |
| Worst drawdown (1 year) | -83.1% |
| Average daily value traded | 0.78M HKD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Guangzhou R&F Properties is a Chinese property developer based in Guangzhou. The company builds and sells residential developments and commercial properties, and it also owns and operates hotels and investment properties that generate rental income. Its customers are mainly homebuyers and businesses in mainland China, with some projects and hotel operations elsewhere. The group carries out property development, property investment and hotel management as its main activities.
The shares are listed on the Hong Kong Stock Exchange in Hong Kong under the code 2777, and the price on this page is in Hong Kong dollars (HKD). Our dividend records, which start in 2019, show payments in 3 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Guangzhou R&F Properties Co Ltd (2777) trades on the Hong Kong Stock Exchange in Hong Kong. It last closed at HKD 0.191 on 27 October 2026.
Its price-based Market X-Ray is 22 out of 100 (a weak price profile), ranking 2,383 of 2,619 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 68.7% and over the last three months it fell 12.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Hong Kong Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 8 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -42.7% | ||
| From 52-week high | -71.9% | ||
| Momentum | 18 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -12.4% | ||
| 6-month return | -49.1% | ||
| 12-month return, skipping the last month | -77.5% | ||
| Stability (higher is calmer) | 20 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 73.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -83.1% | ||
| Liquidity | 60 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.78M HKD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −11.6% |
|---|---|
| 1 month | +39.4% |
| 3 months | −12.4% |
| 6 months | −49.1% |
| 1 year | −68.7% |
| 3 years | −82.6% |
| 5 years | −96.4% |
Signals
| 50-day / 200-day average | 0.177 / 0.333 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.020 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 9 Sep 2021 | HKD 0.1200 |
| 1 Jun 2021 | HKD 0.7494 |
| 10 Sep 2020 | HKD 0.4253 |
| 2 Jun 2020 | HKD 0.9370 |
| 12 Sep 2019 | HKD 0.4681 |
| 3 Jun 2019 | HKD 0.9445 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Hong Kong Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.